{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:47:37Z","timestamp":1784306857752,"version":"3.55.0"},"reference-count":30,"publisher":"ALUNA","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wiad Lek"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:p>Multiple sclerosis (MS) is a disease of the central nervous system (CNS), characterized by chronic inflammation associated with autoimmune damage to myelin and axons leading to neurodegeneration. Although the etiology is not fully understood, some factors that increase the risk of disease have been identified. One of the key elements of multidisciplinary approach to the management of MS is a properly balanced diet, e.g. Swank diet. Its main assumption is to reduce the supply of animal fats in favor of fats of plant origin, which contain polyunsaturated fatty acids omega-3. One of the factors influencing the course of the disease is vitamin D deficiency. In 80-90% it is synthesized by exposure to the sun, while the other 10-20% may be supplied with ingested food. Although elevated plasma homocysteine levels have been demonstrated in MS patients, there is no need to modify the supply of B vitamins. Further studies are necessary to show the correlation between the supply of B vitamins and the course of the disease. Due to the antioxidant effect, it is recommended to include products that are sources of vitamin A, E and C, glutathione, coenzyme Q10. It is also beneficial to include compounds from the polyphenol group: quercetin, resveratrol and curcumin. Through proper nutrition model it is also possible to reduce side effects of applied medications, such as constipation, what improves patients\u2019 quality of life. Diet therapy is a key element supporting pharmacotherapy in patients with multiple sclerosis.<\/jats:p>","DOI":"10.36740\/wlek202209115","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T14:18:18Z","timestamp":1666189098000},"page":"2131-2135","source":"Crossref","is-referenced-by-count":3,"title":["THE ROLE OF DIET IN MULTIPLE SCLEROSIS"],"prefix":"10.36740","volume":"75","author":[{"given":"Vivian","family":"Carbogno-Barnabe","sequence":"first","affiliation":[{"name":"DOCTORAL SCHOOL, FACULTY OF HEALTH SCIENCES IN KATOWICE, MEDICAL UNIVERSITY OF SILESIA, KATOWICE, POLAND"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"\u0141abuz-Roszak","sequence":"additional","affiliation":[{"name":"DEPARTMENT OF NEUROLOGY, INSTITUTE OF MEDICAL SCIENCES, UNIVERSITY OF OPOLE, OPOLE, POLAND"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22436","published-online":{"date-parts":[[2022]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Fanara S, Aprile M, Iacono S, et al. The role of nutritional lifestyle and physical activity in multiple sclerosis pathogenesis and management: a narrative review. Nutrients. 2021;13:3774.","DOI":"10.3390\/nu13113774"},{"key":"ref1","unstructured":"2. Bonek R, Maciejek Z. Naturalny przebieg stwardnienia rozsianego. Aktualn Neurol. 2009;9(2):116-125 [in Polish]."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Stoiloudis P, Kesidou E, Bakirtzis C, et al. The role of diet and interventions on multiple sclerosis: a review. Nutrients. 2022;14:1150.","DOI":"10.3390\/nu14061150"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Karolczak-Kulesza M, Karolczak-Tomkiewicz A, Chlebowska E. Neuropatia nerwu wzrokowego w przebiegu stwardnienia rozsianego i innych chor\u00f3b neurodegeneracyjnych \u2013 metody post\u0119powania diagnostyczno-terapeutycznego. Ophihaterapy. 2018;3(19):187-193 [in Polish].","DOI":"10.24292\/01.ot.300918.7"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5. Kami\u0144ska J, Koper OM, Piechal K, et al. Stwardnienie rozsiane - etiopatogeneza i mo\u017cliwo\u015bci diagnostyczne. Postepy Hig Med Dosw. 2017;71:551-563 [in Polish].","DOI":"10.5604\/01.3001.0010.3836"},{"key":"ref5","unstructured":"6. Rosiak K, Zago\u017cd\u017con P. Czynniki \u015brodowiskowe w epidemiologii stwardnienia rozsianego. Probl Hig Epidemiol. 2012;93(4):627-631[in Polish]."},{"key":"ref6","unstructured":"7. Sedaghat F, Jessri M, Behrooz M, et al. Mediterranean diet adherence and risk of multiple sclerosis: a case control study. Asia Pac J Clin Nutr. 2016;25(2):377-384."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Davis C, Bryan J, Hodgson J, et al. Definition of the mediterranean diet: a literature review. Nutrients. 2015;7:9139-9153.","DOI":"10.3390\/nu7115459"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Konikowska K, Regulska-Ilow B. Rola diety w stwardnieniu rozsianym. Postepy Hig Med Dosw. 2014;68:325-333[in Polish].","DOI":"10.5604\/17322693.1095838"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Simpson-Yap S, Nag N, Jakaria M, et al. Sociodemographic and clinical characteristics of diet adherence and relationship with quality in an international cohort of people with multiple sclerosis. Mult Scler Relat Disord. 2021;56:103307.","DOI":"10.1016\/j.msard.2021.103307"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Wahls TL, Chenard CA, Snetselaar LG. Review of two popular eating plans within the multiple sclerosis community: low saturated fat and modified paleolithic. Nutrients.2019;11:352.","DOI":"10.3390\/nu11020352"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Zhornitsky S, McKay KA, Metz LM, et al. Cholesterol and markers of cholesterol turnover in multiple sclerosis: Relationship with disease outcomes. Mult Scler Relat Disord. 2016;5:53-65.","DOI":"10.1016\/j.msard.2015.10.005"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses. 1986;21(2):193-200","DOI":"10.1016\/0306-9877(86)90010-1"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Smolders J, Torklidsen O, Camu W, et al. An update on vitamin d and disease activity in multiple sclerosis. CNS Drugs. 2019; 33(12):1187- 1199.","DOI":"10.1007\/s40263-019-00674-8"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. De La Puente Yag\u00fce M, Yurrita LC, Caba\u00f1as MJC, et al. Role of vitamin d in athletes and their performance: current concepts and new trends. Nutrients. 2020;12:579.","DOI":"10.3390\/nu12020579"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16. Jeon SM, Shin EA. Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 2018;50:20.","DOI":"10.1038\/s12276-018-0038-9"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Jagannath VA, Filippini G, Di Pietrantonj C, et al. Vitamin D for the management of multiple sclerosis (Review). Cochrane Database of Systematic Reviews. 2018;9. doi: 10.1002\/14651858.CD008422.pub3.","DOI":"10.1002\/14651858.cd008422.pub3"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Sandberg L, Bistr\u00f6m M, Salzer J, et al. Vitamin D and axonal injury in multiple sclerosis. Mult Scler. 2016;22(8):1027-1031.","DOI":"10.1177\/1352458515606986"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Kfoczy\u0144ska M, Kucharska A, Si\u0144ska B. Rola witaminy D w stwardnieniu rozsianym. Post\u0119py Hig Med Dos. 2015;69:440-446 [in Polish].","DOI":"10.5604\/17322693.1148709"},{"key":"ref19","unstructured":"20. Najafi MR, Shaygannajad V, Mirpourian M, et al. Vitamin B12 deficiency and mutiple sclerosis; is there any association? Int J Prev Med. 2012;3(4):286-289."},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"21. Nemazannikova N, Mikkelsen K, Stojanovska L, et al. Is there a link between vitamin B and multiple sclerosis? Med Chem. 2018;14(2):170-180.","DOI":"10.2174\/1573406413666170906123857"},{"key":"ref21","unstructured":"22. D\u0105browska-Bender M, Mirowska-Guzel D. \u017bywienie chorych na stwardnienie rozsiane \u2013 przegl\u0105d pi\u015bmiennictwa. Pol Przegl Neurol. 2015;11(3):136-151 [in Polish]."},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Riccio P, Rossano R. Nutrition facts in multiple sclerosis. ASN Neuro. 2015;7(1):1-20.","DOI":"10.1177\/1759091414568185"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Angeloni C, Malaguti M, Barbalace MC, et al. Bioactivity of olive oil phenols in neuroprotection. Int J Mol Sci. 2017;18:2230.","DOI":"10.3390\/ijms18112230"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Mart\u00ednez-Lapiscina EH, Clavero P, Toledo E, et al. Virgin olive oil supplementation and long-term cognition: The PREDIMED-NAVARRA randomised trial. J Nutr Health Aging.2013;17(6):544-552.","DOI":"10.1007\/s12603-013-0027-6"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Aristotelous P, Stefanakis M, Pantzaris M, et al. The effects of specific omega-3 and omega-6 polyunsaturated fatty acids and antioxidant vitamins on gait and functional capacity parameters in patients with relapsing-remitting multiple sclerosis. Nutrients. 2021;13:3661.","DOI":"10.3390\/nu13103661"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"27. Dusek P, Hofer T, Alexander J, et al. Cerebral iron deposition in neurodegeneration. Biomolecules. 2022;12:714.","DOI":"10.3390\/biom12050714"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"28. Stankiewicz JM, Neema M, Ceccarelli A. Iron and multiple sclerosis. Neurobiol Aging. 2014;35(2):51-58.","DOI":"10.1016\/j.neurobiolaging.2014.03.039"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Zakrzewska-Pniewska B, Adamczyk-Sowa M, Brola W, et al. Leczenie i post\u0119powanie objawowe w stwardnieniu rozsianym. Rekomendacje Sekcji SM i Neuroimmunologii Polskiego Towarzystwa Neurologicznego. Pol Przegl Neurol. 2019;15(4):191-217 [in Polish].","DOI":"10.5603\/ppn.2019.0033"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Parks NE, Jackson-Tarlton CS, Vacchi L, et al. Dietary interventions for multiple sclerosis-related outcomes (Review). Cochrane Database of Systemativ Reviews. 2020;5. https:\/\/www.cochrane.org\/CD004192\/ MS_dietary-interventions-multiple-sclerosis-related-outcomes . [Access: February 2022]","DOI":"10.1002\/14651858.cd004192.pub4"}],"container-title":["Wiadomo\u015bci Lekarskie"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T14:20:37Z","timestamp":1666189237000},"score":1,"resource":{"primary":{"URL":"https:\/\/wiadlek.pl\/wp-content\/uploads\/archive\/2022\/09\/WLek202209115.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022]]},"published-print":{"date-parts":[[2022,9]]}},"URL":"https:\/\/doi.org\/10.36740\/wlek202209115","archive":["Internet Archive"],"relation":{},"ISSN":["0043-5147"],"issn-type":[{"value":"0043-5147","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}